MedMira Inc. (TSXV:MIR)
0.0750
-0.0050 (-6.25%)
Jun 13, 2025, 10:09 AM EDT
MedMira Revenue
MedMira had revenue of 69.00K CAD in the quarter ending January 31, 2025, a decrease of -53.60%. This brings the company's revenue in the last twelve months to 276.73K, down -32.14% year-over-year. In the fiscal year ending July 31, 2024, MedMira had annual revenue of 412.57K, down -4.61%.
Revenue (ttm)
276.73K
Revenue Growth
-32.14%
P/S Ratio
202.86
Revenue / Employee
5.32K
Employees
52
Market Cap
56.14M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2024 | 412.57K | -19.96K | -4.61% |
Jul 31, 2023 | 432.53K | -519.60K | -54.57% |
Jul 31, 2022 | 952.13K | -1.19M | -55.60% |
Jul 31, 2021 | 2.14M | 1.23M | 133.33% |
Jul 31, 2020 | 919.07K | 391.63K | 74.25% |
Jul 31, 2019 | Pro | Pro | Pro |
Jul 31, 2018 | Pro | Pro | Pro |
Jul 31, 2017 | Pro | Pro | Pro |
Jul 31, 2016 | Pro | Pro | Pro |
Jul 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
dentalcorp Holdings | 1.58B |
Sienna Senior Living | 896.45M |
Green Thumb Industries | 1.64B |
Extendicare | 1.47B |
Cronos Group | 179.08M |
WELL Health Technologies | 990.34M |
Trulieve Cannabis | 1.71B |
Curaleaf Holdings | 1.89B |
MedMira News
- 2 months ago - MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense - Accesswire
- 2 months ago - Medmira reports Q2 results - Seeking Alpha
- 2 months ago - MedMira Reports Second Quarter Results FY2025 - Accesswire
- 3 months ago - MedMira Announces Partnership with MediGroup Physician Services in the United States - Accesswire
- 3 months ago - MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada - Accesswire
- 5 months ago - MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications - Accesswire
- 5 months ago - MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications - Accesswire
- 5 months ago - MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use - Accesswire